NovaSphere Bio is a biomedical startup reimagining how we prevent infections in high-risk surgeries. Our flagship technology, NovaSpheres, is a dual-phase antibiotic delivery system engineered to reduce surgical site infections (SSIs), particularly in spinal procedures where infection can lead to devastating complications. By integrating our biodegradable polymer-based microparticles into an in situ-forming gel, NovaSphere Bio offers localized, sustained, and controlled antibiotic delivery directly at the surgical site.
Our approach minimizes risk of infection, reduces hospitalization costs, and aligns with current trends in precision surgery and infection control. Unlike traditional IV antibiotics or passive coatings, NovaSphere Bio’s technology adapts to the dynamics of wound healing, offering a targeted solution with translational potential across multiple surgical fields, including orthopedics and trauma care.
Founded by a multidisciplinary team of aspiring physicians, scientists, and biomedical engineers, NovaSphere Bio is committed to advancing next-generation intraoperative solutions that improve patient outcomes and surgical safety. At NovaSphere Bio, we’re not just delivering solutions, we’re delivering peace of mind. Our mission is simple: Reimagining an Infection-Free Future.
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- East Lansing.
Novasphere Bio Questions
Novasphere Bio's LinkedIn profile is https://www.linkedin.com/company/novasphere-bio
Novasphere Bio has
4 employees.
View email and phone details for 4
employees at Novasphere Bio.
Novasphere Bio's industry is
Biotechnology Research
Novasphere Bio's top competitors are
Neurox,
A2 Biosocial,
Bioinnovation Group At Uc Davis,
Indigoblue Innovations,
Neurona Therapeutics,
Msu Research Foundation,
Fortera,
Phoenix Flavors & Fragrances,
Summer Springboard,
Pickle Robot Company.
Novasphere Bio's categories are Biotechnology Research
